Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

12.9K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.9K
Amyloid Fibrils03:03

Amyloid Fibrils

6.9K
6.9K
Subviral Agents01:29

Subviral Agents

748
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
748
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Reservoir of Infection01:30

Reservoir of Infection

37
Infectious diseases arise from intricate interactions between pathogens and their reservoirs. A reservoir of infection refers to the natural habitat where a pathogen lives, grows, and multiplies, serving as a continual source of infection. Reservoirs are broadly classified as either living or nonliving, and each plays a unique role in disease transmission, significantly influencing public health interventions and control strategies.Humans act as reservoirs for a wide array of pathogens,...
37
Bacterial Phylum Spirochaetes01:30

Bacterial Phylum Spirochaetes

1.2K
Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-mGluR5 encephalitis: distinctive clinical features and antibody patterns in the Chinese population.

Frontiers in immunology·2026
Same author

PrP<sup>C</sup>-facilitated cell signaling activates phospholipase Cɣ1 and triggers an Arc/Arg3.1 response in mouse and iPSC-derived human neurons.

Stem cell reports·2026
Same author

A single large-scale mitochondrial DNA deletion presenting as rapidly progressive dementia in a 35-year-old male.

NPJ dementia·2026
Same author

Standardizing "Rapid": Applying the Clinical Dementia Rating to Define Rapidly Progressive Dementia.

Neurology·2025
Same author

Correction: The Natural History Study and Biomarker Collection of the Clinical Research Consortium for the Study of Cerebellar Ataxia (CRC-SCA).

Cerebellum (London, England)·2025
Same author

"It may cost you your money, it costs you your life": a framework for financial hardship in dementia.

The Gerontologist·2025
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Mar 29, 2026

Prion Safety Laboratory Swipe Test
06:01

Prion Safety Laboratory Swipe Test

Published on: February 14, 2025

1.5K

Prion Diseases.

Michael D Geschwind

    Continuum (Minneapolis, Minn.)
    |December 4, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Human prion diseases present in sporadic, genetic, and acquired forms, with varied clinical features. New diagnostic tests show high specificity, but treatments remain elusive, though a protective gene variant offers hope.

    More Related Videos

    Procedures for Identifying Infectious Prions After Passage Through the Digestive System of an Avian Species
    12:00

    Procedures for Identifying Infectious Prions After Passage Through the Digestive System of an Avian Species

    Published on: November 6, 2013

    11.7K
    Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
    12:57

    Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

    Published on: January 8, 2015

    16.7K

    Related Experiment Videos

    Last Updated: Mar 29, 2026

    Prion Safety Laboratory Swipe Test
    06:01

    Prion Safety Laboratory Swipe Test

    Published on: February 14, 2025

    1.5K
    Procedures for Identifying Infectious Prions After Passage Through the Digestive System of an Avian Species
    12:00

    Procedures for Identifying Infectious Prions After Passage Through the Digestive System of an Avian Species

    Published on: November 6, 2013

    11.7K
    Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
    12:57

    Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

    Published on: January 8, 2015

    16.7K

    Area of Science:

    • Neuroscience
    • Infectious Diseases
    • Genetics

    Background:

    • Human prion diseases are fatal neurodegenerative disorders caused by misfolded prion proteins.
    • These diseases manifest in sporadic, genetic, and acquired forms, each with distinct clinical presentations.

    Purpose of the Study:

    • To provide an updated overview of the clinical aspects of human prion diseases.
    • To highlight the diverse spectrum of presentations and diagnostic advancements.

    Main Methods:

    • Review of current literature on human prion diseases.
    • Analysis of recent findings in diagnostic testing and genetic research.

    Main Results:

    • New antemortem diagnostic tests for prion diseases demonstrate high specificity.
    • Genetic prion diseases exhibit slow progression and varied phenotypes, sometimes mimicking other neurodegenerative disorders.
    • Clinical trials for prion diseases have not yet shown survival benefits.

    Conclusions:

    • Sporadic Creutzfeldt-Jakob disease is the most prevalent form.
    • Genetic prion diseases are challenging to diagnose due to heterogeneous clinical and neuropathologic features.
    • Acquired prion diseases are rare and decreasing due to preventative measures.